Diagnosis of interstitial fibrosis and tubular atrophy in kidney allograft: Implementation of MicroRNAs
MetadataShow full item record
Chronic allograft nephropathy is the major cause of kidney allograft loss, and recent advances in immunosuppression therapy do not alter the picture. Interstitial fibrosis and tubular atrophy is an early event that starts early after engraftment and even could be found in recipients with good allograft function. Serum creatinine and estimated glomerular filtration rate have limited clinical roles in estimating the histopathological changes and graft fibrosis. Recent progress in microRNA research has created a great promise to identify new diagnostic biomarkers and therapeutic targets in renal fibrosis.
Showing items related by title, author, creator and subject.
Upregulated expression of circulating micrornas in kidney transplant recipients with interstitial fibrosis and tubular atrophy Zununi Vahed, S; Zonouzi, AP; Ghanbarian, H; Ghojazadeh, M; Samadi, N; Ardalan, M (2017)Introduction. The discovery of circulating microRNAs (miRNAs), as potential noninvasive diagnostic biomarkers, has opened new avenues of research for identifying transplant patients with chronic allograft dysfunction. The ...
Tuning of major signaling networks (TGF-?, Wnt, Notch and Hedgehog) by miRNAs in human stem cells commitment to different lineages: Possible clinical application Aval, SF; Lotfi, H; Sheervalilou, R; Zarghami, N (2017)Two distinguishing characteristics of stem cells, their continuous division in the undifferentiated state and growth into any cell types, are orchestrated by a number of cell signaling pathways. These pathways act as a ...
Ardalan, MR (2015)Context: Renal Transplantation is the most effective treatment for patients with end-stage renal disease, which is fortunately available in the developing countries, even for poor people. Nonetheless, the way forward should ...